0.4714
price down icon2.20%   -0.0106
after-market Dopo l'orario di chiusura: .45 -0.0214 -4.54%
loading

Acurx Pharmaceuticals Inc Azioni (ACXP) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Operating Expenses
14.40%
4.3779
5.1146 3.115 3.4452 2.903
Income/Loss From Continuing Operations Before Tax
14.40%
-4.3779
-5.1146 -3.115 -3.4452 -2.903
Income/Loss From Continuing Operations After Tax
14.40%
-4.3779
-5.1146 -3.115 -3.4452 -2.903
Net Income/Loss
14.40%
-4.3779
-5.1146 -3.115 -3.4452 -2.903
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
3,872%
15.47
0.3896 13.01 12.19 11.64
Diluted Average Shares
3,872%
15.47
0.3896 13.01 12.19 11.64
Basic Earnings Per Share
26.32%
-0.28
-0.38 -0.24 -0.28 -0.25
Diluted Earnings Per Share
26.32%
-0.28
-0.38 -0.24 -0.28 -0.25
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$20.52
price up icon 1.08%
$35.59
price down icon 2.14%
$22.61
price down icon 7.90%
$96.95
price down icon 0.87%
$110.05
price up icon 0.05%
biotechnology ONC
$240.99
price down icon 1.83%
Capitalizzazione:     |  Volume (24 ore):